| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2014PLoSO...989998D |
| P356 | DOI | 10.1371/JOURNAL.PONE.0089998 |
| P932 | PMC publication ID | 3960093 |
| P698 | PubMed publication ID | 24646516 |
| P5875 | ResearchGate publication ID | 260949433 |
| P50 | author | Vitaliy Ovod | Q59943870 |
| Justyna A Dobrowolska Zakaria | Q60376755 | ||
| Tom P Kasten | Q114573545 | ||
| Wendy C. Sigurdson | Q114573558 | ||
| Yafei Huang | Q114573573 | ||
| Tammie L. Benzinger | Q56154010 | ||
| John C. Morris | Q56839763 | ||
| Randall J. Bateman | Q39888114 | ||
| P2860 | cites work | [11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease | Q60451990 |
| Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease | Q48103753 | ||
| Turnover of amyloid beta-protein in mouse brain and acute reduction of its level by phorbol ester. | Q48519738 | ||
| Circadian characteristics of sleep propensity function in healthy elderly: a comparison with young adults | Q48733289 | ||
| Clinical and neurobiological correlates of soluble amyloid precursor proteins in the cerebrospinal fluid. | Q51392734 | ||
| Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study. | Q51872146 | ||
| Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. | Q51983988 | ||
| Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. | Q51986028 | ||
| Fluctuations of CSF amyloid-beta levels: implications for a diagnostic and therapeutic biomarker. | Q53285087 | ||
| Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE | Q22010705 | ||
| Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity | Q22010912 | ||
| Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein | Q22251280 | ||
| Global prevalence of dementia: a Delphi consensus study | Q24603249 | ||
| Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle | Q24644961 | ||
| Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein | Q24650599 | ||
| Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor | Q27675616 | ||
| Protein kinase C-dependent alpha-secretase competes with beta-secretase for cleavage of amyloid-beta precursor protein in the trans-golgi network | Q28143129 | ||
| Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein | Q28260479 | ||
| Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B | Q29012704 | ||
| Sleep drives metabolite clearance from the adult brain | Q29620065 | ||
| Effects of age and amyloid deposition on Aβ dynamics in the human central nervous system | Q34215733 | ||
| The nature and metabolism of potentially amyloidogenic carboxyl-terminal fragments of the Alzheimer beta/A4-amyloid precursor protein: some technical notes | Q35582069 | ||
| Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women | Q35630404 | ||
| Protein phosphorylation inhibits production of Alzheimer amyloid beta/A4 peptide | Q36578141 | ||
| Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women | Q36694340 | ||
| Disruption of the sleep-wake cycle and diurnal fluctuation of β-amyloid in mice with Alzheimer's disease pathology | Q36845156 | ||
| β-amyloid dynamics in human plasma | Q37254727 | ||
| Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity | Q37357625 | ||
| Alzheimer's disease: the challenge of the second century | Q37862502 | ||
| Biology and pathophysiology of the amyloid precursor protein | Q37869935 | ||
| Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults | Q40253365 | ||
| Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients | Q44574707 | ||
| High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. | Q45192211 | ||
| In vivo beta-secretase 1 inhibition leads to brain Abeta lowering and increased alpha-secretase processing of amyloid precursor protein without effect on neuregulin-1. | Q46835118 | ||
| Correlations between soluble α/β forms of amyloid precursor protein and Aβ38, 40, and 42 in human cerebrospinal fluid | Q48088716 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e89998 | |
| P577 | publication date | 2014-03-19 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Diurnal patterns of soluble amyloid precursor protein metabolites in the human central nervous system | |
| P478 | volume | 9 |
| Q48444707 | Acute function of secreted amyloid precursor protein fragment APPsα in synaptic plasticity. |
| Q41325973 | Amyloid-β Protein Precursor Cleavage Products in Postmortem Ventricular Cerebrospinal Fluid of Alzheimer's Disease Patients |
| Q38780800 | Associations Between β-Amyloid Kinetics and the β-Amyloid Diurnal Pattern in the Central Nervous System |
| Q38595534 | Biobanking of Cerebrospinal Fluid for Biomarker Analysis in Neurological Diseases |
| Q26830098 | Body fluid biomarkers in Alzheimer's disease |
| Q92593401 | Brain-related proteins as serum biomarkers of acute, subconcussive blast overpressure exposure: A cohort study of military personnel |
| Q33735544 | CNS amyloid-β, soluble APP-α and -β kinetics during BACE inhibition. |
| Q47587631 | Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry |
| Q97527703 | Cerebrospinal fluid biomarkers of Alzheimer's disease in a cohort of adults with Down syndrome |
| Q54234721 | Distinct in vivo roles of secreted APP ectodomain variants APPsα and APPsβ in regulation of spine density, synaptic plasticity, and cognition. |
| Q33647053 | Diurnal oscillation of CSF Aβ and other AD biomarkers |
| Q39317466 | Does sleep disturbance affect the amyloid clearance mechanisms in Alzheimer's disease? |
| Q47563259 | Effect of sleep on overnight CSF amyloid-β kinetics. |
| Q37237233 | No diurnal variation of classical and candidate biomarkers of Alzheimer's disease in CSF. |
| Q90263774 | Peripheral Amyloid Precursor Protein Derivative Expression in Fragile X Syndrome |
| Q26801663 | Preanalytical Confounding Factors in the Analysis of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: The Issue of Diurnal Variation |
| Q42118491 | Re-evaluation of soluble APP-α and APP-β in cerebrospinal fluid as potential biomarkers for early diagnosis of dementia disorders |
| Q48940844 | Systems Pharmacology Analysis of the Amyloid Cascade after β-Secretase Inhibition Enables the Identification of an Aβ42 Oligomer Pool |
| Q37645358 | The effects of different familial Alzheimer's disease mutations on APP processing in vivo |
| Q47431150 | Understanding the roles of mutations in the amyloid precursor protein in Alzheimer disease. |
| Q40354888 | Viral gene transfer of APPsα rescues synaptic failure in an Alzheimer's disease mouse model. |
Search more.